Form 4 for IRMD IRADIMED CORP
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-15 · accession 0000898432-21-000730 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-17 | 2021-11-15+ | IRMD | Scott Christopher K. | COO, CFO, Sec | S - Sale | $40.03 | -8,285 | 28.6K | -22% | -$331.6K |
| DM | 2021-11-17 | 2021-11-15+ | IRMD | Scott Christopher K. | COO, CFO, Sec | A - Grant | $9.84 | +8,285 | 30.6K | +37% | +$81.5K |
| DM | 2021-11-17 | 2021-11-15+ | IRMD | Scott Christopher K. | COO, CFO, Sec | M - OptEx | $0.00 | -8,285 | 28.7K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-17 | S | D | 2,003 | $40.01 | 28,595 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $40.00 to $40.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected. |
| 2 | Common | Common Stock | 2021-11-17 | A | A | 2,003 | $9.84 | 30,598 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-16 | S | D | 4,255 | $40.00 | 28,595 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-16 | A | A | 4,255 | $9.84 | 32,850 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-15 | S | D | 2,027 | $40.10 | 28,595 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $40.00 to $41.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected. |
| 6 | Common | Common Stock | 2021-11-15 | A | A | 2,027 | $9.84 | 30,622 | D | — | — | |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-17 | M | D | 2,003 | $0.00 | 26,715 | D | $9.84 · — to 2024-12-15 | 2,003 Common Stock | (F3) This option was granted on 12-15-2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-15 | M | D | 2,027 | $0.00 | 32,973 | D | $9.84 · — to 2024-12-15 | 2,027 Common Stock | (F3) This option was granted on 12-15-2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 9 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-16 | M | D | 4,255 | $0.00 | 28,718 | D | $9.84 · — to 2024-12-15 | 4,255 Common Stock | (F3) This option was granted on 12-15-2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. |